Trials / Recruiting
RecruitingNCT06894381
Characteristics and Results of Patients Treated by Therapeutic Intensification
Characteristics and Results of Patients Treated by Therapeutic Intensification Followed by Autograft of Peripheral Stem Cells and Admitted to Intensive Care and Intensive Care: Single-center Retrospective Analysis
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 24 (estimated)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Many studies have focused on patients treated with allogeneic peripheral stem cell transplantation; few studies have until now been carried out to describe the characteristics and results of autografted patients and to attempt to determine possible prognostic factors. However, it is estimated that nearly 5% of autograft patients require MIR care. The investigators therefore wish to conduct a retrospective study including patients treated by therapeutic intensification followed by autograft of hematopoietic stem cells and admitted to the MIR department of the Hautepierre hospital of the University Hospitals of Strasbourg (HUS) within thirty days following initiation of chemotherapy.
Conditions
Timeline
- Start date
- 2024-01-20
- Primary completion
- 2025-12-01
- Completion
- 2025-12-20
- First posted
- 2025-03-25
- Last updated
- 2025-03-25
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06894381. Inclusion in this directory is not an endorsement.